vs
Side-by-side financial comparison of Ceribell, Inc. (CBLL) and Clearfield, Inc. (CLFD). Click either name above to swap in a different company.
Clearfield, Inc. is the larger business by last-quarter revenue ($34.3M vs $24.8M, roughly 1.4× Ceribell, Inc.). Clearfield, Inc. runs the higher net margin — -1.8% vs -54.6%, a 52.8% gap on every dollar of revenue. Clearfield, Inc. produced more free cash flow last quarter ($-2.4M vs $-11.0M).
Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.
Clearfield, Inc. is a company headquartered in Minneapolis, Minnesota. The company produces fiber optic products.
CBLL vs CLFD — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $24.8M | $34.3M |
| Net Profit | $-13.5M | $-614.0K |
| Gross Margin | 87.3% | 33.2% |
| Operating Margin | -58.9% | -5.3% |
| Net Margin | -54.6% | -1.8% |
| Revenue YoY | — | -3.2% |
| Net Profit YoY | — | 67.8% |
| EPS (diluted) | $-0.35 | $-0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $24.8M | $34.3M | ||
| Q3 25 | $22.6M | $23.4M | ||
| Q2 25 | $21.2M | $49.9M | ||
| Q1 25 | $20.5M | $47.2M | ||
| Q4 24 | — | $29.7M | ||
| Q3 24 | $17.2M | $5.6M | ||
| Q2 24 | — | $48.8M | ||
| Q1 24 | — | $36.9M |
| Q4 25 | $-13.5M | $-614.0K | ||
| Q3 25 | $-13.5M | $-9.1M | ||
| Q2 25 | $-13.6M | $1.6M | ||
| Q1 25 | $-12.8M | $1.3M | ||
| Q4 24 | — | $-1.9M | ||
| Q3 24 | $-10.4M | — | ||
| Q2 24 | — | $-447.0K | ||
| Q1 24 | — | $-5.9M |
| Q4 25 | 87.3% | 33.2% | ||
| Q3 25 | 88.3% | 53.2% | ||
| Q2 25 | 88.1% | 30.5% | ||
| Q1 25 | 87.9% | 30.1% | ||
| Q4 24 | — | 29.2% | ||
| Q3 24 | 87.3% | — | ||
| Q2 24 | — | 21.9% | ||
| Q1 24 | — | 7.7% |
| Q4 25 | -58.9% | -5.3% | ||
| Q3 25 | -64.8% | 10.3% | ||
| Q2 25 | -70.5% | 3.0% | ||
| Q1 25 | -69.3% | 0.6% | ||
| Q4 24 | — | -6.9% | ||
| Q3 24 | -57.8% | — | ||
| Q2 24 | — | -4.7% | ||
| Q1 24 | — | -26.4% |
| Q4 25 | -54.6% | -1.8% | ||
| Q3 25 | -59.6% | -38.8% | ||
| Q2 25 | -64.4% | 3.2% | ||
| Q1 25 | -62.4% | 2.8% | ||
| Q4 24 | — | -6.4% | ||
| Q3 24 | -60.6% | — | ||
| Q2 24 | — | -0.9% | ||
| Q1 24 | — | -16.0% |
| Q4 25 | $-0.35 | $-0.04 | ||
| Q3 25 | $-0.37 | $-0.65 | ||
| Q2 25 | $-0.38 | $0.11 | ||
| Q1 25 | $-0.36 | $0.09 | ||
| Q4 24 | — | $-0.13 | ||
| Q3 24 | $-1.85 | — | ||
| Q2 24 | — | $-0.04 | ||
| Q1 24 | — | $-0.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $159.3M | $96.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $155.3M | $249.7M |
| Total Assets | $195.8M | $268.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $159.3M | $96.4M | ||
| Q3 25 | $168.5M | $106.0M | ||
| Q2 25 | $177.4M | $117.2M | ||
| Q1 25 | $182.7M | $112.0M | ||
| Q4 24 | — | $113.0M | ||
| Q3 24 | $14.1M | $129.0M | ||
| Q2 24 | — | $123.8M | ||
| Q1 24 | — | $142.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $2.2M | ||
| Q2 24 | — | $2.1M | ||
| Q1 24 | — | — |
| Q4 25 | $155.3M | $249.7M | ||
| Q3 25 | $164.1M | $256.2M | ||
| Q2 25 | $172.2M | $264.5M | ||
| Q1 25 | $180.9M | $265.9M | ||
| Q4 24 | — | $267.4M | ||
| Q3 24 | $-136.0M | $275.8M | ||
| Q2 24 | — | $274.6M | ||
| Q1 24 | — | $279.2M |
| Q4 25 | $195.8M | $268.1M | ||
| Q3 25 | $199.5M | $306.2M | ||
| Q2 25 | $207.7M | $314.7M | ||
| Q1 25 | $213.5M | $310.9M | ||
| Q4 24 | — | $303.2M | ||
| Q3 24 | $47.1M | $315.3M | ||
| Q2 24 | — | $318.1M | ||
| Q1 24 | — | $315.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.01× | ||
| Q2 24 | — | 0.01× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.8M | $-1.4M |
| Free Cash FlowOCF − Capex | $-11.0M | $-2.4M |
| FCF MarginFCF / Revenue | -44.2% | -7.1% |
| Capex IntensityCapex / Revenue | 0.7% | 2.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-41.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-10.8M | $-1.4M | ||
| Q3 25 | $-11.1M | — | ||
| Q2 25 | $-7.5M | $7.9M | ||
| Q1 25 | $-11.4M | $3.0M | ||
| Q4 24 | — | $7.2M | ||
| Q3 24 | — | $22.2M | ||
| Q2 24 | — | $4.0M | ||
| Q1 24 | — | $-5.7M |
| Q4 25 | $-11.0M | $-2.4M | ||
| Q3 25 | $-11.5M | — | ||
| Q2 25 | $-7.6M | $7.5M | ||
| Q1 25 | $-11.6M | $654.0K | ||
| Q4 24 | — | $5.1M | ||
| Q3 24 | — | $18.2M | ||
| Q2 24 | — | $2.8M | ||
| Q1 24 | — | $-7.7M |
| Q4 25 | -44.2% | -7.1% | ||
| Q3 25 | -50.8% | — | ||
| Q2 25 | -35.9% | 15.1% | ||
| Q1 25 | -56.4% | 1.4% | ||
| Q4 24 | — | 17.1% | ||
| Q3 24 | — | 323.0% | ||
| Q2 24 | — | 5.8% | ||
| Q1 24 | — | -20.8% |
| Q4 25 | 0.7% | 2.9% | ||
| Q3 25 | 1.6% | 2.0% | ||
| Q2 25 | 0.3% | 0.8% | ||
| Q1 25 | 0.7% | 5.1% | ||
| Q4 24 | — | 7.0% | ||
| Q3 24 | — | 71.4% | ||
| Q2 24 | — | 2.5% | ||
| Q1 24 | — | 5.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 4.93× | ||
| Q1 25 | — | 2.30× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
CLFD
Segment breakdown not available.
